Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders

Bone Marrow Transplantation

Volumn 26, Issue 2, 2000, Pages 127-132

  Altes A ^a   Lopez R ^b   Martino, R ^b   Martinez, C ^b   Cabezudo, E ^b   Munoz L ^b   Santamaria A ^b   Perea, G ^b   Briones, J ^b   Salar, A ^b   Sureda, A ^b   Brunet, S ^b   Madoz, P ^b   Sierra, J ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b NONE

Author keywords

Chemotherapy; Lymphoma; PBPC mobilization

Indexed keywords

CD34 ANTIGEN; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; IFOSFAMIDE; METHYLPREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CELL KINETICS; CELL MOTILITY; CLINICAL ARTICLE; COLONY FORMING UNIT GM; FEMALE; HUMAN; HUMAN CELL; LEUKAPHERESIS; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTIVARIATE ANALYSIS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SALVAGE THERAPY; THROMBOCYTE COUNT;

EID: 0343628015     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702476     Document Type: Article

References (24)

1. Gratwohl A, Hermans J, Baldomero H. Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1997; 19: 407-419.
2. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous hone marrow transplants and allogeneic hone marrow transplants. Bone Marrow Transplant 1992; 9: 227-284.
3. Russell NH, McQuaker G, Stainer C et al. Stem cell mobilisation in lymphoproliferative diseases. Bone Marrow Transplant 1998; 22: 935-940.
4. Bensinger WI, Longin K, Appelbaum F et al. PB stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rh G-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-831.
5. To LB, Haylock D, Simmons PJ, Juttner C. The biology and clinical uses of blood stem cells. Blood 1997; 89: 2233-2258.
6. Lopez R, Martino R, Sureda A et al. Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience. Haematologica 1999; 84: 350-355.
7. Garcia J, Martinez E. La criopreservación de precursores hematopoyéticos: su papel en Hematología y Oncología. Biol Clin Hematol 1983; 5: 99-107.
8. Pike BL, Robinson WA. Human bone marrow colony growth in agar gel. J Cell Physiol 1970; 76: 77-84.
9. Martinez, C, Mateu R, Sureda A et al. Peripheral blood stem cell mobilization following salvage chemotherapy (IAPVP-16) plus granulocyte colony-stimulating factor and autografting for non-Hodgkin's lymphoma. Transplant Proc 1995; 27: 2355-2356.
10. 2) after salvage chemotherapy for lymphoma. Bone Marrow Transplant 1997; 20: 855-858.
11. Lopez R, Martino R, Brunet S et al. Salvage chemotherapy with IAPVP-16 for advanced refractory or relapsed follicular lymphomas. Haematologica 1999; 84: 911-916.
12. Bender J, To LB, Williams S, Schwartzberg L. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992; 1: 329-334.
13. Haynes AP, Hunter A, McQuaker G et al. Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant 1995; 16: 359-363.
14. Moskowitz CH, Bertino JR, Glassman JR et al. Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. J Clin Oncol 1999; 17: 3776-3785.
15. Rosenfeld CS, Shadduck RK, Zeigler ZR et al. Cyclophosphamide-mobilized peripheral blood stem cell in patients with lymphoid malignancies. Bone Marrow Transplant 1995; 15: 433-438.
16. Haas R, Möhle R, Frühauf S et al. Patients characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-3794.
17. Olivieri A, Offidani M, Ciniero L et al. Optimization of the yield of PBSC for autotransplantation mobilized by high dose chemotherapy and G-CSF: proposal for a mathematical model. Bone Marrow Transplant 1994; 14: 273-278.
18. Koumakis G, Vassilomanolakis M, Hatzichristou H et al. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single leukapheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies. Bone Marrow Transplant 1996; 18: 1065-1072.
19. McQuaker IG, Haynes AP, Stainer C et al. Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol 1997; 98: 228-233.
20. Weaver CH, Schwartzberg LS, Birch R et al. Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patients. Transfusion 1997; 37: 896-903.
21. Watts MJ, Sullivan AM, Jamieson E et al. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol 1997; 15: 535-546.
22. Armitage S, Hargreaves R, Samson D et al. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 1997; 20: 587-591.
23. Engelhardt M, Winkler J, Waller C et al. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF. Bone Marrow Transplant 1997; 19: 529-537.
24. + cell count predicts progenitor cell yield. Haematologica 1999; 84: 32-35.